|
|
||||||||
American Journal of Clinical Nutrition, Vol 65, 1858-1866, Copyright © 1997 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
BM Winklhofer-Roob, H Ellemunter, M Fruhwirth, SE Schlegel-Haueter, G Khoschsorur, MA van't Hof and DH Shmerling
Department of Pediatrics, University of Zurich, Switzerland.
Vitamin C status and possible associations with the disease process in cystic fibrosis (CF) patients were investigated. Plasma vitamin C concentrations in patients from two different mid-European populations (Swiss, n = 62; Austrian, n = 60) taking no or low-dose vitamin C from multivitamin supplements did not differ from each other or from control subjects (n = 34). Vitamin C concentrations decreased with age (5.05 mumol.L-1, y-1). When followed up for 12 mo, patients had the highest plasma vitamin C concentrations in February and the lowest in May and August (P < 0.01); the decrease in vitamin C was accompanied by increases in plasma malondialdehyde (P < 0.001) and tumor necrosis factor alpha concentrations (P < 0.01). During supplementation with vitamin E for 2 mo or beta-carotene for 12 mo vitamin C concentrations did not change. They correlated inversely with white blood cell count (r = -0.36, P = 0.008), bands (r = -0.36, P = 0.02), alpha 1-acid glycoprotein (r = -0.45, P = 0.002), interleukin 6 (r = -0.46, P = 0.0006), and neutrophil elastase/alpha 1-proteinase inhibitor complexes (r = -0.34, P = 0.02). In patients with vitamin C concentrations < 40 mumol/L, all indexes of inflammation were relatively high, whereas those with concentrations > 80 mumol/L (upper quartile of control subjects) showed clearly lower values. These results are consistent with the hypothesis that by scavenging oxygen free radicals vitamin C interacts with an inflammation-amplifying cycle of activation of alveolar macrophages and neutrophils, release of proinflammatory cytokines and oxygen free radicals, and inactivation of antiproteases.
This article has been cited by other articles:
![]() |
P. K Drain, R. Kupka, F. Mugusi, and W. W Fawzi Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy Am. J. Clinical Nutrition, February 1, 2007; 85(2): 333 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I Back, C. Frindt, D. Nohr, J. Frank, R. Ziebach, M. Stern, M. Ranke, and H. K Biesalski Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am. J. Clinical Nutrition, August 1, 2004; 80(2): 374 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fischer, C. Schwarzer, and B. Illek Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel PNAS, March 9, 2004; 101(10): 3691 - 3696. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Harik-Khan, D. C. Muller, and R. A. Wise Serum Vitamin Levels and the Risk of Asthma in Children Am. J. Epidemiol., February 15, 2004; 159(4): 351 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L Dreyfuss and W. W Fawzi Micronutrients and vertical transmission of HIV-1 Am. J. Clinical Nutrition, June 1, 2002; 75(6): 959 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Wood, D. A. Fitzgerald, P. G. Gibson, D. M. Cooper, C. E. Collins, and M. L. Garg Oxidative Stress in Cystic Fibrosis: Dietary and Metabolic Factors J. Am. Coll. Nutr., April 1, 2001; 20(2): 157 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Renner, R Rath, P Rust, S Lehr, T. Frischer, I Elmadfa, and I Eichler Effects of {beta}-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis Thorax, January 1, 2001; 56(1): 48 - 52. [Abstract] [Full Text] |
||||
![]() |
W. FAWZI Nutritional Factors and Vertical Transmission of HIV-1 Epidemiology and Potential Mechanisms Ann. N.Y. Acad. Sci., November 1, 2000; 918(1): 99 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. ROOB, G. KHOSCHSORUR, A. TIRAN, J. H. HORINA, H. HOLZER, and B. M. WINKLHOFER-ROOB Vitamin E Attenuates Oxidative Stress Induced by Intravenous Iron in Patients on Hemodialysis J. Am. Soc. Nephrol., March 1, 2000; 11(3): 539 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ikeda, F. Horio, and A. Kakinuma Ascorbic Acid Deficiency Changes Hepatic Gene Expression of Acute Phase Proteins in Scurvy-Prone ODS Rats J. Nutr., May 1, 1998; 128(5): 832 - 838. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |